ADVB - Company ID 0001941029
The table below shows Advanced Biomed Inc.'s cash flow statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Operating cash flow | -$1.95M | -$5.83M | -$2.13M |
| Capital expenditure | - | $31.65K | $74.11K |
| Investing cash flow | -$2.51M | -$31.65K | -$74.11K |
| Dividends paid | - | - | - |
| Stock buybacks | - | - | - |
| Financing cash flow | $1.97M | $5.93M | $1.87M |
Advanced Biomed Inc. reported operating cash flow of -$1.95M for fiscal year 2026. That is up 66.6% from -$5.83M in fiscal 2025. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.